US · NEU · CHEMICALS - SPECIALTY
NewMarket Corporation (NEU) intrinsic value and stock valuation
$697.47as of 2026-11-21 · Mkt cap 8.11B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
NewMarket Corporation DCF and intrinsic value
InvestorsCraft values NEU with the Chepakovich two-stage DCF model — currently rated fairly valued. How the model works · Run your own DCF prefilled from NEU’s statements →
NewMarket Corporation Graham Number
Graham Number: $436.10d — the price is above the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2011–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- Ternium S.A. (TX) $45.85
- Gerdau S.A. (GGB) $4.16
- Westlake Corporation (WLK) $57.95
- Element Solutions Inc (ESI) $29.52
- Iamgold Corporation (IAG) $14.44
- Eastman Chemical Company (EMN) $58.77
- Axalta Coating Systems Ltd. (AXTA) $34.12
- Sasol Limited (SSL) $11.52
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $2.73B | $2.79B | $2.7B | $2.76B | $2.36B |
| Operating income | $543.7M | $590M | $483.1M | $355.1M | $257.8M |
| Net income | $418.8M | $462.4M | $388.9M | $279.5M | $190.9M |
| EPSd | $44.6M | $48.4M | $40.6M | $27.8M | $17.7M |
| Operating cash flow | $569M | $519.6M | $576.8M | $108.6M | $165.3M |
| Capital expenditure | -$-77.64M | -$-57.32M | -$-48.29M | -$-56.17M | -$-78.93M |
| Free cash flow | $491.3M | $462.3M | $528.5M | $52.5M | $86.4M |
| Total assets | $3.49B | $3.13B | $2.31B | $2.41B | $2.56B |
| Total debt | $976.7M | $1.06B | $733.6M | $1.09B | $1.23B |
| Net debt | $899.1M | $981.6M | $621.7M | $1.02B | $1.15B |
| Total equity | $1.78B | $1.46B | $1.08B | $762.4M | $762.1M |
| Cash and short-term investments | $77.6M | $77.5M | $111.9M | $68.7M | $459.2M |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $2.73B | $2.79B | $2.7B | $2.76B | $2.36B |
| Cost of revenue | $1.87B | $1.9B | $1.93B | $2.12B | $1.81B |
| Gross profit | $857.4M | $886.4M | $772.5M | $640.5M | $547.7M |
| Research and development expenses | $132.1M | $124.9M | $138M | $140.3M | $144M |
| Selling, general and administrative expenses | $181.6M | $171.4M | $151.5M | $145.1M | $146M |
| Other expenses | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating expenses | $313.7M | $296.3M | $289.5M | $285.4M | $289.9M |
| Cost and expenses | $2.18B | $2.2B | $2.22B | $2.41B | $2.1B |
| Interest income | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest expense | $39.7M | $57.4M | $37.4M | $35.2M | $34.2M |
| Depreciation and amortization | $122.4M | $117M | $78M | $82.3M | $119.3M |
| Ebitda | $722.7M | $758.4M | $604.3M | $465.2M | $401.1M |
| Operating income | $543.7M | $590M | $483.1M | $355.1M | $257.8M |
| Total other income/expenses, net | $16.8M | -$-5.93M | $5.92M | -$-7.41M | -$-10.23M |
| Income before tax | $560.6M | $584.1M | $489M | $347.7M | $247.6M |
| Income tax expense | $141.8M | $121.7M | $100.1M | $68.2M | $56.6M |
| Net income | $418.8M | $462.4M | $388.9M | $279.5M | $190.9M |
| Weighted average shares outstanding | $9.39M | $9.56M | $9.58M | $10M | $10.8M |
| Weighted average diluted shares outstanding | $9.39M | $9.56M | $9.58M | $10M | $10.8M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $77.6M | $77.5M | $111.9M | $68.7M | $459.2M |
| Net receivables | $422.1M | $395.5M | $432.4M | $453.7M | $391.8M |
| Inventory | $502.3M | $505.4M | $456.2M | $631.4M | $498.5M |
| Total current assets | $1.06B | $1.03B | $1.04B | $1.19B | $1.39B |
| Property, plant and equipment, net | $884.8M | $839.8M | $760.3M | $722.4M | $784.8M |
| Goodwill and intangible assets | $941.2M | $750.4M | $124.6M | $126.1M | $127.8M |
| Long-term investments | $0.00 | $2.75M | $2.88M | $2.99M | $0.00 |
| Total non-current assets | $2.43B | $2.1B | $1.27B | $1.21B | $1.17B |
| Total assets | $3.49B | $3.13B | $2.31B | $2.41B | $2.56B |
| Accounts payable | $238.4M | $225.9M | $231.1M | $273.3M | $246.1M |
| Short-term debt | $16.2M | $15.3M | $15.1M | $15.6M | $365.1M |
| Deferred revenue | $18.4M | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current liabilities | $419.3M | $374.5M | $364.2M | $423.9M | $725.1M |
| Long-term debt | $960.5M | $1.04B | $718.5M | $1.07B | $867.5M |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $1.29B | $1.29B | $867.7M | $1.22B | $1.07B |
| Capital lease obligations | $93.3M | $87.8M | $90M | $85M | $93.3M |
| Total liabilities | $1.71B | $1.67B | $1.23B | $1.64B | $1.8B |
| Common stock | $2.39M | $0.00 | $2.13M | $0.00 | $0.00 |
| Retained earnings | $1.67B | $1.43B | $1.1B | $834.4M | $844.4M |
| Accumulated other comprehensive income (loss) | $106.8M | $32.9M | -$-21.07M | -$-72M | -$-82.23M |
| Total equity | $1.78B | $1.46B | $1.08B | $762.4M | $762.1M |
| Total investments | $0.00 | $2.75M | $2.88M | $2.99M | $375.9M |
| Total debt | $976.7M | $1.06B | $733.6M | $1.09B | $1.23B |
| Net debt | $899.1M | $981.6M | $621.7M | $1.02B | $1.15B |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $418.8M | $462.4M | $388.9M | $279.5M | $190.9M |
| Depreciation and amortization | $122.4M | $117M | $78M | $82.3M | $84.3M |
| Stock-based compensation | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Change in working capital | $22.3M | -$-23.33M | $134.3M | -$-204.64M | -$-116.36M |
| Accounts receivable | -$-10.65M | $36.2M | $31.6M | -$-73.09M | -$-53.99M |
| Inventory | $32.8M | -$-36.54M | $192.5M | -$-166.56M | -$-96.2M |
| Accounts payable | $16M | -$-7.64M | -$-59.18M | $35.5M | $60.4M |
| Net cash provided by operating activities | $569M | $519.6M | $576.8M | $108.6M | $165.3M |
| Investments in property, plant and equipment | -$-77.64M | -$-57.32M | -$-48.29M | -$-56.17M | -$-78.93M |
| Acquisitions, net | -$-213.45M | -$-681.48M | $0.00 | $0.00 | $0.00 |
| Net cash used for investing activities | -$-291.08M | -$-738.8M | -$-48.29M | $315.9M | -$-461.41M |
| Common stock issued | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock repurchased | -$-77.22M | -$-31.91M | -$-42.86M | -$-207.47M | -$-196.22M |
| Dividends paid | -$-105.93M | -$-95.9M | -$-85.03M | -$-84.26M | -$-85.91M |
| Net cash used for financing activities | -$-279.14M | $185.8M | -$-487.59M | -$-439.36M | $255.1M |
| Net change in cash | $120K | -$-34.46M | $43.2M | -$-14.59M | -$-41.87M |
| Cash at end of period | $77.6M | $77.5M | $111.9M | $68.7M | $83.3M |
| Operating cash flow | $569M | $519.6M | $576.8M | $108.6M | $165.3M |
| Capital expenditure | -$-77.64M | -$-57.32M | -$-48.29M | -$-56.17M | -$-78.93M |
| Free cash flow | $491.3M | $462.3M | $528.5M | $52.5M | $86.4M |
Line items
Line items
Line items
About NewMarket Corporation
NewMarket Corporation, through its various subsidiaries, operates primarily in the specialty chemicals sector, specializing in the creation and supply of petroleum additives. The company furnishes an extensive selection of lubricant additives that are vital for optimizing performance across a wide array of automotive and industrial machinery. These formulations cater to diverse applications, including engine oils (used in passenger cars, motorcycles, heavy-duty commercial vehicles, locomotives, and marine engines), driveline systems (such as transmission and axle fluids, and lubricants for off-road powertrains), and a variety of industrial fluids (like hydraulic fluids, greases, industrial gear lubricants, and specialized turbine oils). Essentially, these additives are engineered to enhance components wherever metal surfaces engage in motion. Additionally, NewMarket engineers fuel additives that contribute to the efficiency of the oil refining process and notably improve the properties and performance of different fuels, including gasoline, diesel, and biofuels. These essential products are distributed to a broad spectrum of clients, encompassing industrial enterprises, governmental entities, original equipment manufacturers, and individual end-users. Beyond its core additive offerings, the corporation is also involved in producing antiknock compounds, delivering contract manufacturing services, and owns and oversees a real estate holding located in Virginia. Founded in 1887, NewMarket Corporation is headquartered in Richmond, Virginia, and maintains a significant global footprint with operations spanning North America, Latin America, the Asia Pacific region, Europe, the Middle East, Africa, and India.
- CEO
- Thomas E. Gottwald
- Employees
- 2.05K
- Beta
- 0.57
Included in
Explore
Frequently asked questions
What is the intrinsic value of NewMarket Corporation (NEU)?
NewMarket Corporation (NEU) is currently fairly valued based on the InvestorsCraft IC model — IC value is within 20% of the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is NEU undervalued?
NEU trades at a price of $697.47 (Nov 21, 2026): fairly valued — IC value is within 20% of the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.